About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, ...
Abbott (NYSE: ABT) announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald(TM). Abbott's CELL-DYN Emerald ...
Gov. Phil Murphy announced Friday the acquisition of 15 point-of-care ID NOW testing instruments from the federal government to expand access to COVID-19 testing in New Jersey. The portable, rapid ...
ABBOTT PARK, Ill., Oct. 22 Abbott (NYSE: ABT)has received a 2007 Chicago Innovation Award for its m2000(TM) moleculardiagnostic instrument(www.abbott.com/global/url ...
SAN DIEGO--(BUSINESS WIRE)--Banyan announced today that it will provide Abbott, a global healthcare leader, a license for its traumatic brain injury (TBI) blood biomarkers – Ubiquitin Carboxy-terminal ...
The state Department of Health has distributed 12 Abbott ID NOW COVID-19 rapid test instruments to the counties, the DOH announced Friday. “Having this capability to test a critically ill patient ...
WASHINGTON, July 28 Abbott (NYSE: ABT) willpreview an upcoming addition to the CELL-DYN(R) family of hematologyinstruments, the Emerald(TM), at the American Association of ClinicalChemistry (AACC) ...
About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, ...
SAN DIEGO--(BUSINESS WIRE)--Banyan announced today that it will provide Abbott, a global healthcare leader, a license for its traumatic brain injury (TBI) blood biomarkers – Ubiquitin Carboxy-terminal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback